Healthcare & Life Sciences
Putnam Investments has announced that it will launch three actively managed, transparent ETFs in the coming months, pending completion of the regulatory filing process.
AXS Investments has announced the launch of two new ETFs: the AXS 2X Innovation ETF (Nasdaq: TARK) and the AXS Short China Internet ETF (Nasdaq: SWEB).
Elemental Advisors Inc has launched PSYK ETF (NYSE: PSYK), a thematic ETF that tracks the performance of the Enhanced Consciousness Index, principally comprised of companies involved in the research, development, production and/or use of psychedelics to address medical conditions in legal pharmacological applications under the applicable jurisdiction’s laws.
December saw the launch of the antidote to ESG with the BAD Investment Company’s first ETF, based on betting, alcohol and drugs.
Thematic ETF issuers HANetf have written a detailed report on their outlook for 2022 for a number of themes.
ETF issuer WisdomTree has launched the WisdomTree BioRevolution UCITS ETF (WDNA).
ETP provider GraniteShares, which offers a range of 3x short and 3x leveraged ETPs on popular UK, US, and French stocks, says the investment outlook for the healthcare sector is positive.
Frankfurt-based index provider Solactive writes that in the wake of its massive negative impacts, the pandemic has accelerated the development of new pharmaceuticals and vaccines.
Frankfurt-based Solactive writes that the COVID-19 pandemic has put a strain on the global healthcare system.